Histogen to Report Second Quarter 2020 Earnings on August 13, 2020

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO) announced its second-quarter financial results will be released on August 13, 2020, after market close. The company specializes in developing innovative restorative therapeutics aimed at enhancing the body's natural healing processes. Histogen's proprietary technology includes cell-conditioned media and extracellular matrix materials from hypoxia-induced multipotent cells, targeting hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.

Positive

• Histogen focuses on potential first-in-class restorative therapeutics.
• Innovative technology platform utilizes hypoxia-induced multipotent cells.
• Targets multiple therapeutic indications including hair growth and joint regeneration.

Negative

• None.

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the second quarter ended June 30, 2020 will be released after the close of market on Thursday, August 13, 2020.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen Inc. release its second-quarter financial results?

Histogen Inc. will release its second-quarter financial results on August 13, 2020, after market close.

What is the focus of Histogen Inc.?

Histogen Inc. focuses on developing first-in-class restorative therapeutics that support the body's natural healing processes.

What therapeutic areas does Histogen's technology address?

Histogen's technology addresses hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.

What is the stock symbol for Histogen Inc.?

The stock symbol for Histogen Inc. is HSTO.